Lenalidomide Promotes Thrombosis Formation, but Does Not Affect Platelet Activation in Multiple Myeloma

Lenalidomide Promotes Thrombosis Formation, but Does Not Affect Platelet Activation in Multiple Myeloma

Lenalidomide, a well-established drug for the treatment of multiple myeloma, significantly enhances patients’ survival. Previous clinical studies have demonstrated that its main side effect is an increased risk of thrombotic events. However, the underlying mechanism remains unexplored. Therefore, th...

Full description

Bibliographic Details
Main Authors: Panpan Li, Bei Xu, Jiadai Xu, Yanyan Xu, Yawen Wang, Chen Chen, Peng Liu
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:International Journal of Molecular Sciences
Subjects:
multiple myeloma
immunomodulatory drugs
thrombosis
platelet
Online Access:https://www.mdpi.com/1422-0067/24/18/14097

Internet

https://www.mdpi.com/1422-0067/24/18/14097

Similar Items